Kabra Drugs Ltd.
| BSE: 524322 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE323K01017 |
| BSE 00:00 | 16 Sep | 5.15 |
0 (0.00%) |
OPEN
5.67 |
HIGH
5.67 |
LOW
5.15 |
| NSE 05:30 | 01 Jan | Kabra Drugs Ltd |
| OPEN | 5.67 |
| PREVIOUS CLOSE | 5.15 |
| VOLUME | 216 |
| 52-Week high | 5.67 |
| 52-Week low | 2.67 |
| P/E | |
| Mkt Cap.(Rs cr) | 2 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Kabra Drugs Ltd. (KABRADRUGS) - Competition
| COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
| Sun Pharma.Inds. | 770.25 | 184,806.08 | 12,803.21 | 2,139.70 | 32,510.54 |
| Divi's Lab. | 5,131.15 | 136,206.38 | 6,798.61 | 1,954.72 | 9,297.17 |
| Dr Reddy's Labs | 4,889.15 | 81,345.68 | 13,349.10 | 2,186.40 | 18,266.10 |
| Cipla | 954.15 | 76,966.51 | 13,900.58 | 2,468.28 | 20,166.89 |
| Apollo Hospitals | 4,894.20 | 70,368.81 | 9,153.00 | 105.00 | 8,226.00 |
| Gland Pharma | 3,932.00 | 64,563.44 | 3,462.88 | 997.01 | 5,909.86 |
| Piramal Enterp. | 2,615.00 | 62,406.97 | 1,824.70 | 39.90 | 29,983.67 |
| Cadila Health. | 557.95 | 57,117.34 | 7,790.40 | 1,476.20 | 16,841.70 |
| Torrent Pharma. | 3,112.30 | 52,666.34 | 6,450.83 | 1,137.85 | 10,618.60 |
| Alkem Lab | 3,895.00 | 46,564.72 | 7,219.68 | 1,685.08 | 9,195.63 |
| Biocon | 377.45 | 45,316.65 | 2,028.40 | 280.50 | 8,024.20 |
| Abbott India | 20,564.25 | 43,699.03 | 4,310.02 | 690.69 | 2,844.49 |
| Aurobindo Pharma | 745.80 | 43,696.42 | 15,823.68 | 3,112.91 | 19,952.13 |
| Lupin | 950.15 | 43,136.81 | 11,055.93 | 1,258.62 | 19,354.36 |
| Max Healthcare | 381.25 | 36,826.84 | 1,079.68 | -164.45 | 6,439.88 |
| Laurus Labs | 651.20 | 34,943.39 | 4,768.72 | 956.11 | 4,255.44 |
| Dr Lal Pathlabs | 3,978.65 | 33,158.07 | 1,490.56 | 280.11 | 1,320.83 |
| Ipca Labs. | 2,495.00 | 31,649.08 | 5,139.16 | 1,140.77 | 5,028.39 |
| Pfizer | 5,878.60 | 26,894.60 | 2,238.55 | 497.61 | 2,494.06 |
| Glaxosmi. Pharma | 1,532.95 | 25,969.71 | 3,193.74 | 357.57 | 1,798.50 |
Quick Links for Kabra Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
